Qidni Labs is inviting up to 30 patients with kidney failure to take part in research studying the “Qidni/D”, an investigational hemodialysis device, as a possible treatment for kidney failure.

Participants are invited to complete a 15-minute survey with questions about their experience with kidney care in Alberta.

The purpose of this study is to determine if spironolactone reduces death or hospitalization for heart failure and is well tolerated in patients that require dialysis.

A study examining the impact of sodium deposition on common symptoms experienced by people with impaired kidney function.

This study will test whether nabilone, a synthetic (non-natural) medication derived from cannabis, improves symptoms of itch in hemodialysis compared to placebo.

Volunteers will come together to advise on a tool to capture the current state of the network’s IDEA practices, analyze the results, and co-develop a plan to address any gaps.

A new patient/public advisory team will help make organ and tissue donation and transplantation more equitable for 2SLGBTQIA+ people.

Are you living with Type 1 Diabetes? Use your experience to help the Diabetes community.

Members work together by sharing their perspectives to support excellence in the delivery of independent hemodialysis care in BC.